Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « KwdFr.i » - entrée « Betacoronavirus (effets des médicaments et des substances chimiques) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Betacoronavirus (croissance et développement) < Betacoronavirus (effets des médicaments et des substances chimiques) < Betacoronavirus (enzymologie)  Facettes :

List of bibliographic references indexed by Betacoronavirus (effets des médicaments et des substances chimiques)

Number of relevant bibliographic references: 193.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000806 (2020) Giuseppe Magro [Italie]SARS-CoV-2 and COVID-19: What are our options? Where should we focus our attention on to find new drugs and strategies?
000817 (2020) Mathieu Gendrot [France] ; Julien Andreani [France] ; Manon Boxberger [France] ; Priscilla Jardot [France] ; Isabelle Fonta [France] ; Marion Le Bideau [France] ; Isabelle Duflot [France] ; Joel Mosnier [France] ; Clara Rolland [France] ; Hervé Bogreau [France] ; Sébastien Hutter [France] ; Bernard La Scola [France] ; Bruno Pradines [France]Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation.
000838 (2020) Seema Rani [Inde] ; Sandeep Grover [Inde] ; Aseem Mehra [Inde] ; Swapnajeet Sahoo [Inde]Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients.
000844 (2020) Anwar M. Hashem [Arabie saoudite] ; Badrah S. Alghamdi [Arabie saoudite] ; Abdullah A. Algaissi [Arabie saoudite] ; Fahad S. Alshehri [Arabie saoudite] ; Abdullah Bukhari [Arabie saoudite] ; Mohamed A. Alfaleh [Arabie saoudite] ; Ziad A. Memish [États-Unis]Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review.
000849 (2020) Awadhesh Kumar Singh [Inde] ; Akriti Singh [Inde] ; Altamash Shaikh [Inde] ; Ritu Singh [Inde] ; Anoop Misra [Inde]Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries.
000858 (2020) Philippe Gautret [France] ; Jean-Christophe Lagier [France] ; Philippe Parola [France] ; Van Thuan Hoang [Viêt Nam] ; Line Meddeb [France] ; Jacques Sevestre [France] ; Morgane Mailhe [France] ; Barbara Doudier [France] ; Camille Aubry [France] ; Sophie Amrane [France] ; Piseth Seng [France] ; Marie Hocquart [France] ; Carole Eldin [France] ; Julie Finance [France] ; Vera Esteves Vieira [France] ; Hervé Tissot Tissot-Dupont [France] ; Stéphane Honoré [France] ; Andreas Stein [France] ; Matthieu Million [France] ; Philippe Colson [France] ; Bernard La Scola [France] ; Véronique Veit [France] ; Alexis Jacquier [France] ; Jean-Claude Deharo [France] ; Michel Drancourt [France] ; Pierre Edouard Fournier [France] ; Jean-Marc Rolain [France] ; Philippe Brouqui [France] ; Didier Raoult [France]Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study.
000864 (2020) Rashmi Ranjan Das [Inde] ; Bijayini Behera [Inde] ; Baijayantimala Mishra [Inde] ; Sushree Samiksha Naik [Inde]Effect of chloroquine and hydroxychloroquine on COVID-19 virological outcomes: An updated meta-analysis.
000886 (2020) Awadhesh Kumar Singh [Inde] ; Akriti Singh [Inde] ; Ritu Singh [Inde] ; Anoop Misra [Inde]"Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis."
000916 (2020) Mario Rivera-Izquierdo [Espagne] ; María Del Carmen Valero-Ubierna [Espagne] ; Juan Luis R-Delamo [Espagne] ; Miguel Ngel Fernández-García [Espagne] ; Silvia Martínez-Diz [Espagne] ; Arezu Tahery-Mahmoud [Espagne] ; Marta Rodríguez-Camacho [Espagne] ; Ana Belén Gámiz-Molina [Espagne] ; Nicolás Barba-Gyengo [Espagne] ; Pablo Gámez-Baeza [Espagne] ; Celia Cabrero-Rodríguez [Espagne] ; Pedro Antonio Guirado-Ruiz [Espagne] ; Divina Tatiana Martín-Romero [Espagne] ; Antonio Jesús Láinez-Ramos-Bossini [Espagne] ; María Rosa Sánchez-Pérez [Espagne] ; José Mancera-Romero [Espagne] ; Miguel García-Martín [Espagne] ; Luis Miguel Martín-Delosreyes [Espagne] ; Virginia Martínez-Ruiz [Espagne] ; Eladio Jiménez-Mejías [Espagne][Therapeutic agents tested in 238 COVID-19 hospitalized patients and their relationship with mortality].
000921 (2020) Saadia Ait Malek [Maroc] ; Imane El Bouchti [Maroc][SARS-CoV-2 infection in a patient treated by hydroxychloroquine and anti TNF α for Inflammatory Rheumatic Disease].
000933 (2020) Moa-Lina Haller ; Marie-Eve Brunner ; Hervé Olivier Zender[Intensive care unit treatment for patients suffering from COVID-19: the Neuchâtel experience].
000960 (2020) Philip M. Carlucci [États-Unis] ; Tania Ahuja [États-Unis] ; Christopher Petrilli [États-Unis] ; Harish Rajagopalan [États-Unis] ; Simon Jones [États-Unis] ; Joseph Rahimian [États-Unis]Zinc sulfate in combination with a zinc ionophore may improve outcomes in hospitalized COVID-19 patients.
000967 (2020) Chunfeng Li [États-Unis] ; Genhong Cheng [États-Unis]Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?
000977 (2020) Daniela Marotto [Italie] ; Piercarlo Sarzi-Puttini [Italie]What is the role of rheumatologists in the era of COVID-19?
000987 (2020) Pavan Kumar Samudrala [Inde] ; Pramod Kumar [Inde] ; Kamlesh Choudhary [Inde] ; Nagender Thakur [Inde] ; Gaurav Suresh Wadekar [Inde] ; Richa Dayaramani [Inde] ; Mukta Agrawal [Inde] ; Amit Alexander [Inde]Virology, pathogenesis, diagnosis and in-line treatment of COVID-19.
000988 (2020) Phulen Sarma [Inde] ; Hardeep Kaur [Inde] ; Harish Kumar [Inde] ; Dhruv Mahendru [Inde] ; Pramod Avti [Inde] ; Anusuya Bhattacharyya [Inde] ; Manisha Prajapat [Inde] ; Nishant Shekhar [Inde] ; Subodh Kumar [Inde] ; Rahul Singh [Inde] ; Ashutosh Singh [Inde] ; Deba Prasad Dhibar [Inde] ; Ajay Prakash [Inde] ; Bikash Medhi [Inde]Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: A systematic review and meta-analysis.
000A13 (2020) John R. Giudicessi [États-Unis] ; Peter A. Noseworthy [États-Unis] ; Paul A. Friedman [États-Unis] ; Michael J. Ackerman [États-Unis]Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19).
000A26 (2020) Marta Guillan [Espagne] ; Javier Villacieros-Alvarez [Espagne] ; Sara Bellido [Espagne] ; Concepcion Perez-Jorge Peremarch [Espagne] ; Victor M. Suarez-Vega [Espagne] ; Maria Aragones-Garcia [Espagne] ; Celina Cabrera-Rojo [Espagne] ; Jose Fernandez-Ferro [Espagne]Unusual simultaneous cerebral infarcts in multiple arterial territories in a COVID-19 patient.
000A40 (2020) Aaron Gazendam [Canada] ; Nicholas Nucci [Canada] ; Seper Ekhtiari [Canada] ; Chetan Gohal [Canada] ; Meng Zhu [Canada] ; Abbey Payne [Canada] ; Mohit Bhandari [Canada]Trials and tribulations: so many potential treatments, so few answers.
000A44 (2020) Shio-Shin Jean [Taïwan] ; Ping-Ing Lee [Taïwan] ; Po-Ren Hsueh [Taïwan]Treatment options for COVID-19: The reality and challenges.
000A66 (2020) Timothy A. West [Australie] ; Sameer Malik [Australie] ; Anastasios Nalpantidis [Australie] ; Tuan Tran [Australie] ; Christine Cannon [Australie] ; Deepak Bhonagiri [Australie] ; Kevin Chan [Australie] ; Elaine Cheong [Australie] ; Jenny Wan Sai Cheong [Australie] ; Winston Cheung [Australie] ; Faisal Choudhury [Australie] ; David Ernest [Australie] ; Claude S. Farah [Australie] ; Shelanah Fernando [Australie] ; Rupa Kanapathipillai [Australie] ; Mark Kol [Australie] ; Brendan Murfin [Australie] ; Haider Naqvi [Australie] ; Asim Shah [Australie] ; Atul Wagh [Australie] ; Samar Ojaimi [Australie] ; Bradley Frankum [Australie] ; Sean Riminton [Australie] ; Karuna Keat [Australie]Tocilizumab for severe COVID-19 pneumonia: Case series of 5 Australian patients.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Betacoronavirus (effets des médicaments et des substances chimiques)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i  \
                -Sk "Betacoronavirus (effets des médicaments et des substances chimiques)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdFr.i
   |clé=    Betacoronavirus (effets des médicaments et des substances chimiques)
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021